Iovance Biotherapeutics, Inc. beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.17 | $-0.11 | +35.3% | Beat |
| Q12026 FY2026 | $-0.19 | $-0.19 | +0.0% | Beat |
| Q42025 FY2025 | $-0.22 | $-0.18 | +18.2% | Beat |
Back to IOVA overview · IOVA holders · IOVA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.